Primary Open-angle Glaucoma
Showing NaN - NaN of 6
Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (PF-04217329 - Lowest Dose, PF-04217329 - Low Dose,
Completed
- Primary Open-Angle Glaucoma
- Ocular Hypertension
- PF-04217329 - Lowest Dose
- +8 more
-
Artesia, California
- +22 more
Apr 6, 2021
Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost, Timolol 0.5%, Placebo Ocular Insert)
Completed
- Primary Open-Angle Glaucoma
- Ocular Hypertension
- Bimatoprost
- +3 more
-
Fayetteville, Arkansas
- +9 more
May 18, 2020
Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost)
Completed
- Primary Open-Angle Glaucoma
- Ocular Hypertension
-
Fayetteville, Arkansas
- +8 more
Mar 26, 2019
Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost)
Completed
- Primary Open-Angle Glaucoma
- Ocular Hypertension
-
Artesia, California
- +9 more
Feb 1, 2019
Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost, Timolol 0.5%, Placebo Eye Drops)
Completed
- Primary Open-Angle Glaucoma
- Ocular Hypertension
- Bimatoprost
- +3 more
-
Artesia, California
- +9 more
Mar 22, 2018
Ocular Hypertension, Primary Open-Angle Glaucoma Trial in Newport Beach (AGN-210961 Formulation 1, AGN-210961 Formulation 2,
Completed
- Ocular Hypertension
- Primary Open-Angle Glaucoma
- AGN-210961 Formulation 1
- +7 more
-
Newport Beach, California(unnamed)
Jul 10, 2014